Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00652678 · ClinicalTrials.gov registry record
Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- 38
- Enrollment target
NCT00652678 is a clinical trial that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 38 participants.
The verdict
NCT00652678 was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- 38 participants
- Enrollment target
Study Summary
Some patients who undergo breast cancer treatment with lumpectomy followed by radiation therapy develop significant late skin and soft tissue changes, resulting in a poor cosmetic outcome. The goal of this study is to try to predict severe tissue reactions by using a combination of three of the latest blood tests, one of which we have developed ourselves.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2006-08 |
| Est. Completion | 2012-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00652678
The ClinicalTrials.gov registry entry for NCT00652678 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00652678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00652678 about?
NCT00652678 is a clinical study titled "Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients". Some patients who undergo breast cancer treatment with lumpectomy followed by radiation therapy develop significant late skin and soft tissue changes, resulting in a poor cosmetic outcome. The goal of this study is to try to predict severe tissue reactions by using a combination of three of the late...
What is the current status of trial NCT00652678?
This trial is currently terminated. The enrollment target is 38 participants. The study started on 2006-08. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT00652678?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.